Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release…
Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules
- Published
- 19 Mar 2025
- Units affected
- 3 products
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-746-05
Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 1000-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-747-10
Duloxetine Delayed-Release Capsules, USP, 60mg, Rx Only, 1000-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-10
- Brand / company
- Breckenridge Pharmaceutical, Inc.
- Codes / lots
- Lot#: 240098C, Expiration: 01/2027. | Lot#: 240225C, Expiration: 01/2027 | Lot#: 240301C, Expiration: 01/2027.
- Distribution
- Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 19 Mar 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.